All content on this site is intended for healthcare professionals only. By acknowledging this message and accessing the information on this website you are confirming that you are a Healthcare Professional. If you are a patient or carer, please visit the International Myeloma Foundation

The Multiple Myeloma Hub uses cookies on this website. They help us give you the best online experience. By continuing to use our website without changing your cookie settings, you agree to our use of cookies in accordance with our updated Cookie Policy

Is dara + VTd the best induction treatment for high-risk patients with newly diagnosed MM?

During the 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT), the Multiple Myeloma Hub spoke to Philippe Moreau, CHU de Nantes, Nantes, FR. We asked, Is dara + VTd the best induction treatment for high-risk patients with newly diagnosed MM?

Is dara + VTd the best induction treatment for high-risk patients with newly diagnosed MM?

Philippe Moreau talks about the use of daratumumab (dara) plus the bortezomib, thalidomide, and dexamethasone (VTd) combination as induction therapy prior to stem cell transplantation. He discusses the findings of the CASSIOPEIA study.

Share: